WISP-3 drives LUAD metastasis by suppressing miR-5004-5p to upregulate MMP-12

Area of Science:

• Oncology
• Molecular Biology
• Cellular Signaling

Background:

• Lung adenocarcinoma (LUAD) exhibits high metastatic potential and poor prognosis.
• The role of WNT1-inducible signaling pathway protein 3 (WISP-3), a member of the cellular communication network (CCN) family, in LUAD progression is not fully understood.
• WISP-3's context-dependent functions necessitate further investigation in specific cancer types like LUAD.

Purpose of the Study:

• To elucidate the function and mechanism of WISP-3 in lung adenocarcinoma (LUAD) metastasis.
• To investigate the signaling pathway regulated by WISP-3 in LUAD.
• To identify potential therapeutic targets within the WISP-3-mediated pathway.

Main Methods:

• Analysis of WISP-3 expression in LUAD tissues and correlation with patient survival.
• In vitro functional assays (cell migration, wound healing) to assess WISP-3's impact on LUAD cell behavior.
• Mechanistic studies involving Src, FAK, microRNA-5004-5p (miR-5004-5p), and matrix metalloproteinase-12 (MMP-12) expression and regulation.

Main Results:

• WISP-3 is significantly upregulated in LUAD and associated with poor patient survival.
• WISP-3 enhances LUAD cell migration and wound healing by activating Src/FAK signaling, leading to miR-5004-5p suppression.
• Suppressed miR-5004-5p results in increased MMP-12 expression; MMP-12 is elevated in LUAD and linked to poor prognosis.

Conclusions:

• WISP-3 promotes LUAD metastasis through a signaling cascade involving Src/FAK activation, miR-5004-5p suppression, and MMP-12 upregulation.
• The WISP-3/Src/FAK/miR-5004-5p/MMP-12 axis represents a novel mechanism driving LUAD progression.
• Targeting this axis holds promise for developing new therapeutic strategies against LUAD metastasis.